TB-500 has no marketing authorisation from any regulatory agency. No human clinical trials of TB-500 specifically have been conducted. The evidence base relies on animal studies of both TB-500 and ...
View full compound profile →Vendors stocking
27
across 6 countries
Total listings
48
43 in stock
Price range
£16.00–£130.00
Median price per mg
£7.00
Most common size
5mg
16 listings
Forms available
lyophilised, pre-mixed pen, vial, tablet, pen
Stock health
90%
26 vendors · 43 listings
16 vendors · 33 listings
£16.00–£130.00
Avg £7.17/mg
3 vendors · 5 listings
€39.95–€129.00
Avg €7.08/mg
3 vendors · 4 listings
CA$54.99–CA$89.99
Avg CA$7.17/mg
3 vendors · 4 listings
$59.99–$72.00
Avg $8.77/mg
1 vendor · 1 listing
zł33.99
Avg zł3.40/mg
1 vendor · 1 listing
2mg
7 listings
Avg price: £20.61
Avg per mg: £10.31
5mg
15 listings
Avg price: £35.52
Avg per mg: £7.10
10mg
13 listings
Avg price: £60.79
Avg per mg: £6.08
20mg
1 listing
Avg price: £129.00
Avg per mg: £6.45
30tablets
1 listing
Avg price: £49.95
Avg per mg: £1.67
This compound is sold as a research chemical and is not approved for human use. Information on this page is compiled from publicly available vendor listings and is provided for informational purposes only. PeptideTrace does not sell peptides, does not facilitate transactions, and does not recommend any vendor. Always verify product quality independently.
Prices last updated: 15 May 2026
Data sourced from 27 vendor websites across 6 countries